|
羟基-PEG3-SS-PEG3-醇
|
H596690-100mg
|
≥98% |
5662-81-7 |
100mg
|
¥ 7980.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羟基-PEG3-DBCO
|
H596683-50mg
|
≥98% |
N/A |
50mg
|
¥ 81.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羟基-PEG3-DBCO
|
H596683-250mg
|
≥98% |
N/A |
250mg
|
¥ 146.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羟基-PEG3-DBCO
|
H596683-100mg
|
≥98% |
N/A |
100mg
|
¥ 109.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
17-(溴乙酰氨基-PEG6-乙基氨基甲酰基)十七烷酸叔丁酯
|
H596677-50mg
|
≥98% |
N/A |
50mg
|
¥ 81.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
17-(溴乙酰氨基-PEG6-乙基氨基甲酰基)十七烷酸叔丁酯
|
H596677-250mg
|
≥98% |
N/A |
250mg
|
¥ 146.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
17-(溴乙酰氨基-PEG6-乙基氨基甲酰基)十七烷酸叔丁酯
|
H596677-100mg
|
≥98% |
N/A |
100mg
|
¥ 109.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羟基-PEG7-DBCO
|
H596649-50mg
|
≥98% |
N/A |
50mg
|
¥ 81.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羟基-PEG7-DBCO
|
H596649-250mg
|
≥98% |
N/A |
250mg
|
¥ 146.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羟基-PEG7-DBCO
|
H596649-100mg
|
≥98% |
N/A |
100mg
|
¥ 109.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
17-(氨基-PEG9-乙基氨基甲酰基)十七烷酸叔丁酯
|
H596508-50mg
|
≥95% |
N/A |
50mg
|
¥ 11760.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
17-(氨基-PEG9-乙基氨基甲酰基)十七烷酸叔丁酯
|
H596508-25mg
|
≥95% |
N/A |
25mg
|
¥ 7980.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
17-(氨基-PEG9-乙基氨基甲酰基)十七烷酸叔丁酯
|
H596508-100mg
|
≥95% |
N/A |
100mg
|
¥ 20580.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
17-(氨基-PEG6-乙基氨基甲酰基)十七烷酸
|
H596383-500mg
|
|
N/A |
500mg
|
¥ 28350.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
17-(氨基-PEG6-乙基氨基甲酰基)十七烷酸
|
H596383-250mg
|
|
N/A |
250mg
|
¥ 15750.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
17-(氨基-PEG6-乙基氨基甲酰基)十七烷酸
|
H596383-100mg
|
|
N/A |
100mg
|
¥ 9450.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
17-(氨基-PEG6-乙基氨基甲酰基)十七烷酸叔丁酯
|
H596382-50mg
|
≥98% |
N/A |
50mg
|
¥ 10080.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
17-(氨基-PEG6-乙基氨基甲酰基)十七烷酸叔丁酯
|
H596382-25mg
|
≥98% |
N/A |
25mg
|
¥ 6720.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
17-(氨基-PEG6-乙基氨基甲酰基)十七烷酸叔丁酯
|
H596382-100mg
|
≥98% |
N/A |
100mg
|
¥ 17850.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羟基氨基双(PEG2-炔丙基)
|
H596285-500mg
|
≥98% |
2100306-77-0 |
500mg
|
¥ 20580.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羟基氨基双(PEG2-炔丙基)
|
H596285-250mg
|
≥98% |
2100306-77-0 |
250mg
|
¥ 13650.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羟基氨基双(PEG2-炔丙基)
|
H596285-100mg
|
≥98% |
2100306-77-0 |
100mg
|
¥ 6720.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羟基-PEG3-甲胺
|
H595818-500mg
|
≥98% |
90430-59-4 |
500mg
|
¥ 13650.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羟基-PEG3-甲胺
|
H595818-250mg
|
≥98% |
90430-59-4 |
250mg
|
¥ 8190.9
|
期货,请咨询 |
|
0 |
阿拉丁 |